TRIPEP AB

Patent Applications and Registrations

Patent applications and USPTO patent grants for TRIPEP AB.The latest application filed is for "glycosylated specificity exchangers".

Company Profile

0.31.9

TRIPEP AB - Huddinge SE
Tripep AB - SE SE
Tripep AB - Stockholm SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Injection needle and device Grant 9,457,183 - Sallberg , et al. October 4, 2	2016-10-04
High affinity adaptor molecules for redirecting antibody specifity Grant 9,284,548 - Collinson , et al. March 15, 2	2016-03-15
T cell receptors specific for immunodominant CTL epitopes of HCV Grant 9,193,778 - Chen November 24, 2	2015-11-24
Glycosylated specificity exchangers Grant 9,079,962 - Sallberg , et al. July 14, 2	2015-07-14
Glycosylated Specificity Exchangers App 20100183635 - Sallberg; Matti ; et al.	2010-07-22
Hepatitis C Virus Codon Optimized Non-structural Ns3/4a Fusion Gene App 20100104592 - Sallberg; Matti	2010-04-29
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 7,638,499 - Sallberg December 29, 2	2009-12-29
Glycosylated Specificity Exchanger App 20090305949 - Sallberg; Matti ; et al.	2009-12-10
Hepatitis C Virus Non-structural Ns3/4a Fusion Gene App 20090215869 - Sallberg; Matti	2009-08-27
Immunogen Platform App 20090214593 - Sallberg; Matti ; et al.	2009-08-27
Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeutics Grant 7,566,812 - Sallberg , et al. July 28, 2	2009-07-28
Indentification Of Compounds That Inhibit Replication Of Human Immunodeficiency Virus App 20090170953 - Balzarini; Jan Maria ; et al.	2009-07-02
Glycosylated specificity exchangers Grant 7,534,435 - Sallberg , et al. May 19, 2	2009-05-19
Glycosylated Specificity Exchangers That Induce An Antibody Dependent Cellular Cytotoxicity (adcc) Response App 20090092631 - Sallberg; Matti ; et al.	2009-04-09
Immunogen Platform App 20090074803 - Sallberg; Matti ; et al.	2009-03-19
Transgenic Mouse Models of Hepatitis C Virus (Hcv) and Identification of Hvc Therapeutics App 20080295185 - Sallberg; Matti ; et al.	2008-11-27
Hepatitis C virus non-structural NS3/4A fusion gene Grant 7,439,347 - Sallberg October 21, 2	2008-10-21
Glycosylated specificity exchangers Grant 7,335,359 - Sallberg , et al. February 26, 2	2008-02-26
Glycosylated specificity exchangers Grant 7,332,166 - Sallberg , et al. February 19, 2	2008-02-19
Glycosylated specificity exchangers Grant 7,318,926 - Sallberg January 15, 2	2008-01-15
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 7,307,066 - Sallberg December 11, 2	2007-12-11
Vaccines containing ribavirin and methods of use thereof Grant 7,261,883 - Sallberg , et al. August 28, 2	2007-08-28
Vaccines containing ribavirin and methods of use thereof Grant 7,244,715 - Sallberg , et al. July 17, 2	2007-07-17
Vaccines containing ribavirin and methods of use thereof Grant 7,244,422 - Sallberg , et al. July 17, 2	2007-07-17
Vaccines containing ribavirin and methods of use thereof Grant 7,241,440 - Sallberg , et al. July 10, 2	2007-07-10
Hepatitis C virus non-structural NS3/4A fusion gene Grant 7,226,912 - Sallberg June 5, 2	2007-06-05
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 7,223,743 - Sallberg May 29, 2	2007-05-29
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 7,022,830 - Sallberg April 4, 2	2006-04-04
Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptors Grant 7,019,111 - Sallberg March 28, 2	2006-03-28
Antiviral composition comprising glycine amide Grant 7,012,129 - Vahlne , et al. March 14, 2	2006-03-14
Hepatitis C virus non-structural NS3/4A fusion gene Grant 6,960,569 - Sallberg November 1, 2	2005-11-01
Specificity exchangers that redirect antibodies to bacterial adhesion receptors Grant 6,933,366 - Sallberg , et al. August 23, 2	2005-08-23
Vaccines containing ribavirin and methods of use thereof Grant 6,858,590 - Sallberg , et al. February 22, 2	2005-02-22
Vaccines containing ribavirin and methods of use thereof Grant 6,680,059 - Sallberg , et al. January 20, 2	2004-01-20
Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen Grant 6,660,842 - Sallberg December 9, 2	2003-12-09
Antigen/antibody specificity exchanger Grant 6,469,143 - Sallberg October 22, 2	2002-10-22
Synthetic peptides that bind to the hepatitis B virus core and e antigens Grant 6,417,324 - Sallberg July 9, 2	2002-07-09
Antigen/antibody specificity exchanger Grant 6,245,895 - Sallberg June 12, 2	2001-06-12
Antigen/antibody specification exchanger Grant 6,040,137 - Sallberg March 21, 2	2000-03-21
Antigen/antibody specificity exchanger Grant 5,869,232 - Sallberg February 9, 1	1999-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.